vs

Side-by-side financial comparison of CME Group (CME) and StoneX Group Inc. (SNEX). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.2B, roughly 1.6× StoneX Group Inc.). StoneX Group Inc. runs the higher net margin — 11.6% vs 0.1%, a 11.5% gap on every dollar of revenue. On growth, StoneX Group Inc. posted the faster year-over-year revenue change (81.0% vs 14.5%). Over the past eight quarters, StoneX Group Inc.'s revenue compounded faster (53.5% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

StoneX Group Inc. is an American financial services company. The company operates in six areas: commercial hedging, global payments, securities, physical commodities, foreign exchange and clearing and execution services (CES).

CME vs SNEX — Head-to-Head

Bigger by revenue
CME
CME
1.6× larger
CME
$1.9B
$1.2B
SNEX
Growing faster (revenue YoY)
SNEX
SNEX
+66.6% gap
SNEX
81.0%
14.5%
CME
Higher net margin
SNEX
SNEX
11.5% more per $
SNEX
11.6%
0.1%
CME
Faster 2-yr revenue CAGR
SNEX
SNEX
Annualised
SNEX
53.5%
10.8%
CME

Income Statement — Q1 2026 vs Q1 2026

Metric
CME
CME
SNEX
SNEX
Revenue
$1.9B
$1.2B
Net Profit
$1.2M
$139.0M
Gross Margin
Operating Margin
0.1%
15.4%
Net Margin
0.1%
11.6%
Revenue YoY
14.5%
81.0%
Net Profit YoY
20.7%
63.3%
EPS (diluted)
$2.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
SNEX
SNEX
Q1 26
$1.9B
Q4 25
$1.6B
$1.2B
Q3 25
$1.5B
$32.7B
Q2 25
$1.7B
$851.2M
Q1 25
$1.6B
$820.4M
Q4 24
$1.5B
$663.1M
Q3 24
$1.6B
$31.1B
Q2 24
$1.5B
$571.8M
Net Profit
CME
CME
SNEX
SNEX
Q1 26
$1.2M
Q4 25
$1.2B
$139.0M
Q3 25
$908.0M
$85.7M
Q2 25
$1.0B
$63.4M
Q1 25
$956.2M
$71.7M
Q4 24
$874.6M
$85.1M
Q3 24
$912.8M
$76.7M
Q2 24
$883.2M
$61.9M
Gross Margin
CME
CME
SNEX
SNEX
Q1 26
Q4 25
Q3 25
3.7%
Q2 25
Q1 25
Q4 24
Q3 24
3.0%
Q2 24
Operating Margin
CME
CME
SNEX
SNEX
Q1 26
0.1%
Q4 25
61.8%
15.4%
Q3 25
63.3%
0.3%
Q2 25
66.7%
-1.3%
Q1 25
67.5%
-1.0%
Q4 24
62.1%
-3.2%
Q3 24
64.6%
-0.0%
Q2 24
65.3%
-4.7%
Net Margin
CME
CME
SNEX
SNEX
Q1 26
0.1%
Q4 25
71.7%
11.6%
Q3 25
59.1%
0.3%
Q2 25
60.6%
7.4%
Q1 25
58.2%
8.7%
Q4 24
57.3%
12.8%
Q3 24
57.6%
0.2%
Q2 24
57.6%
10.8%
EPS (diluted)
CME
CME
SNEX
SNEX
Q1 26
Q4 25
$3.24
$2.50
Q3 25
$2.49
$0.72
Q2 25
$2.81
$1.22
Q1 25
$2.62
$1.41
Q4 24
$2.40
$2.54
Q3 24
$2.50
$2.32
Q2 24
$2.42
$1.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
SNEX
SNEX
Cash + ST InvestmentsLiquidity on hand
$2.4B
$1.6B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$2.5B
Total Assets
$202.0B
$47.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
SNEX
SNEX
Q1 26
$2.4B
Q4 25
$4.5B
$1.6B
Q3 25
$2.6B
$1.6B
Q2 25
$2.1B
$1.3B
Q1 25
$1.5B
$1.3B
Q4 24
$3.0B
$1.4B
Q3 24
$2.4B
$1.3B
Q2 24
$1.9B
$1.2B
Total Debt
CME
CME
SNEX
SNEX
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
SNEX
SNEX
Q1 26
Q4 25
$28.7B
$2.5B
Q3 25
$28.2B
$2.4B
Q2 25
$27.7B
$2.0B
Q1 25
$27.0B
$1.9B
Q4 24
$26.5B
$1.8B
Q3 24
$28.2B
$1.7B
Q2 24
$27.6B
$1.6B
Total Assets
CME
CME
SNEX
SNEX
Q1 26
$202.0B
Q4 25
$198.4B
$47.8B
Q3 25
$187.1B
$45.3B
Q2 25
$179.9B
$34.3B
Q1 25
$157.8B
$31.3B
Q4 24
$137.4B
$29.6B
Q3 24
$137.8B
$27.5B
Q2 24
$123.4B
$25.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
SNEX
SNEX
Operating Cash FlowLast quarter
$-1.3B
Free Cash FlowOCF − Capex
$-1.3B
FCF MarginFCF / Revenue
-106.4%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
-9.08×
TTM Free Cash FlowTrailing 4 quarters
$3.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
SNEX
SNEX
Q1 26
Q4 25
$1.1B
$-1.3B
Q3 25
$968.1M
$3.5B
Q2 25
$1.1B
$1.5B
Q1 25
$1.1B
$-154.5M
Q4 24
$1.0B
$-477.8M
Q3 24
$1.0B
$192.6M
Q2 24
$776.9M
$-622.1M
Free Cash Flow
CME
CME
SNEX
SNEX
Q1 26
Q4 25
$1.1B
$-1.3B
Q3 25
$949.7M
$3.5B
Q2 25
$1.0B
$1.5B
Q1 25
$1.1B
$-169.8M
Q4 24
$991.7M
$-491.4M
Q3 24
$973.2M
$175.9M
Q2 24
$758.7M
$-640.5M
FCF Margin
CME
CME
SNEX
SNEX
Q1 26
Q4 25
66.8%
-106.4%
Q3 25
61.8%
10.7%
Q2 25
61.5%
173.3%
Q1 25
67.1%
-20.7%
Q4 24
65.0%
-74.1%
Q3 24
61.4%
0.6%
Q2 24
49.5%
-112.0%
Capex Intensity
CME
CME
SNEX
SNEX
Q1 26
Q4 25
2.0%
1.3%
Q3 25
1.2%
0.1%
Q2 25
1.1%
1.9%
Q1 25
0.9%
1.9%
Q4 24
1.7%
2.1%
Q3 24
1.9%
0.1%
Q2 24
1.2%
3.2%
Cash Conversion
CME
CME
SNEX
SNEX
Q1 26
Q4 25
0.96×
-9.08×
Q3 25
1.07×
41.18×
Q2 25
1.03×
23.52×
Q1 25
1.17×
-2.15×
Q4 24
1.16×
-5.61×
Q3 24
1.10×
2.51×
Q2 24
0.88×
-10.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

SNEX
SNEX

Principal Gains Net$378.5M32%
Other$293.9M24%
Sales Based Commissions$214.0M18%
Exchange Traded Futures And Options$172.2M14%
Clearing Service$79.0M7%
Equitiesand Fixed Income Commissions$34.3M3%
Underwriting Fees$11.9M1%
Trailing Commissions$7.6M1%
Insurance Annuity Trailing Commissions$4.0M0%
Other Consulting Managementand Account Fees$3.0M0%
Other Commission And Clearing Fees$2.1M0%

Related Comparisons